A panel of judges heard oral arguments in the Grayscale Investments suit against the United States Securities and Trade Commission (SEC) on March 7. Grayscale is challenging the SEC order not to appro...
Tag: Oral
Judges Scrutinize SEC During Oral Arguments in Grayscale Lawsuit
Grayscale and the Securities and Exchange Commission (SEC) have presented their first oral arguments in court regarding the approval/ denial of a Bitcoin a spot ETF product in the United States. Duri...
Grayscale products buoyed following oral arguments in case against the SEC
Grayscale had its day in court, and now the asset manager — and investors in its Grayscale Bitcoin Trust — must await the ruling, which could take three to six months. The asset manager brought...
Court to hear oral arguments in Grayscale’s lawsuit against the SEC in March
A United States appeals court is set to hear the oral arguments relating to Grayscale Investment’s lawsuit against the Securities and Exchange Commission (SEC) over its decision to deny Grayscale’s Bi...
GBTC Lawsuit’s Oral Arguments Scheduled to Begin in March
The court scheduled a date to hear oral arguments in Grayscale’s challenge of SEC’s Bitcoin ETF decision. Grayscale previously anticipated oral arguments to be as soon as Q2 2023. Accordin...
Grayscale, SEC will voice oral arguments over GBTC ETF conversion in March
Grayscale and the U.S. Securities and Exchange Commission will soon have their oral arguments heard in court regarding the conversion of Grayscale Bitcoin Trust into an exchange-traded fund, according...
Grayscale files brief in ETF suit against SEC, oral arguments may come within months
Grayscale filed a reply brief in its appeal of the United States Securities and Exchange Commission (SEC) denial of its application to convert its $12-billion Grayscale Bitcoin Trust (GBTC) into a spo...
Oramed’s oral insulin pill fails; stock is down 72%
Shares of Oramed Pharmaceuticals Inc. ORMP, -76.56% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or secon...
Ripple Ally Files Motion for Oral Argument in Objection to SEC’s Penalty
In recent updates provided by James K. Filan, a Ripple ally and cryptocurrency start-up, LBRY, has requested that the court hear an oral argument for its motion to limit the SEC’s remedies. In a...
CDC is discussing using oral polio vaccine for first time in 20 years to stop New York outbreak
The Centers for Disease Control and Prevention is considering using the oral polio vaccine for the first time in more than 20 years to stop an outbreak in the greater New York City metropolitan area t...
Veru’s stock nearly triples after oral COVID-19 treatment leads to ‘statistically meaningful’ reduction in deaths
Shares of Veru Inc. VERU, +182.30% rocketed 175% toward a 13-month high in afternoon trading Monday, after biopharmaceutical company announced positive results from its Phase 3 trial of its oral COVID...